Current Approaches and Future Directions in the Treatment of Gynecologic Tumors: Molecular Biology, Diagnostic Advancements and Targeted Therapeutic Strategies

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Physiology and Pathology".

Deadline for manuscript submissions: 1 November 2024 | Viewed by 82

Special Issue Editor


E-Mail Website
Guest Editor
Faculty of Dentistry, Carol Davila University of Medicine and Pharmacy, 010221 Bucharest, Romania
Interests: gynecologic oncology; gynecologic cancer surgery; minimally invasive surgery; immunology and genetics of tumors; endometriosis; oncofertility
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Gynecologic tumors represent a serious public health problem as they are associated with high rates of morbidity and mortality. In recent years, the multidisciplinary integrative approach has enabled significant progress to be made in this field, which has led to a better understanding of molecular mechanisms and advanced diagnostic methods, facilitating the implementation of targeted therapies. Although oncologic medicine is becoming increasingly personalized, several knowledge gaps and unsolved problems remain. Thus, future scientific research should offer new perspectives regarding better deciphering the biology of tumor processes, early diagnosis criteria, and therapeutic strategies to improve prognoses.

In this Special Issue, through the lens of the latest medical research, I aim to highlight the continuously growing role of the integrative approach to the management of gynecologic tumors regarding intervention in biomolecular mechanisms, diagnostic criteria, and therapeutic strategies

Dr. Valentin Nicolae Varlas
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gynecologic tumors
  • cervical cancer
  • ovarian cancer
  • endometrial cancer
  • vulvar cancer, vaginal cancer
  • gestational trophoblastic disease
  • molecular mechanisms
  • diagnostic advancements
  • novel therapies

Published Papers

This special issue is now open for submission.
Back to TopTop